F. Menniti Ippolito

Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study

M. Massari, A. Palamara, F. D’Ancona, 2022, BMJ.

Acute liver injury following Garcinia cambogia weight-loss supplementation: case series and literature review

A. Vannacci, E. Gallo, F. Firenzuoli, 2018, Internal and Emergency Medicine.

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients

M. Massari, D. Cereda, G. Trifirò, 2020, Drug Safety.

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022

A. Palamara, G. Rezza, S. Brusaferro, 2022, The Lancet.

Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study

M. Massari, G. Trifirò, E. Bovo, 2022, PLoS medicine.

Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy

A. Folgori, R. Cortese, A. Nicosia, 2018, Journal of Urban Health.

Hepatitis C virus infection in family setting

A. Focà, V. Guadagnino, F. Menniti Ippolito, 1998, European Journal of Epidemiology.

Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection.

A. Costantino, M. Rapicetta, A. Ciccaglione, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The impact of a vaccination campaign against hepatitis B on the further decrease of hepatitis B virus infection in a southern Italian town over 14 years.

M. Rapicetta, G. De Sarro, A. Focà, 2012, European journal of internal medicine.

Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021

M. Massari, A. Palamara, G. Rezza, 2022, Expert Review of Vaccines.

Post-marketing active surveillance of Guillan Barré Syndrome following vaccination with anti-COVID-19 vaccines in persons aged >=12 years in Italy: a multi-database self-controlled case series study

M. Massari, G. Trifirò, A. Puccini, 2023, medRxiv.

Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study

M. Massari, G. Trifirò, E. Bovo, 2022, medRxiv.

Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study

E. Bovo, C. Morciano, F. Menniti Ippolito, 2024, PloS one.